A 72-year-old woman is found to have WBC 15,000/μL with absolute lymphocytosis on routine blood work. Peripheral blood smear shows small, mature-appearing lymphocytes with scant cytoplasm. Lymph nodes are not enlarged. Which investigation is most appropriate to confirm chronic lymphocytic leukemia and exclude other lymphoproliferative disorders?

Explanation

## Flow Cytometry as the Diagnostic Gold Standard for CLL **Key Point:** Flow cytometry with immunophenotyping is the single most important investigation for diagnosing CLL and distinguishing it from other lymphoproliferative disorders. It identifies the characteristic immunophenotype: CD5^+^, CD19^+^, CD23^+^ B lymphocytes with low surface immunoglobulin expression. ## CLL Immunophenotype **High-Yield:** The pathognomonic flow cytometry profile in CLL is: - **CD5^+^ CD19^+^ CD23^+^** (B-cell marker co-expressing T-cell marker CD5) - **Low surface immunoglobulin** (dim or negative) - **CD10 negative** (distinguishes from follicular lymphoma) - **FMC7 negative** (further differentiates from mantle cell lymphoma) ## Comparison of Investigations in CLL Diagnosis | Investigation | Role in CLL | Diagnostic Yield | |---|---|---| | **Flow cytometry (CD5, CD19, CD23)** | **Identifies pathognomonic B-cell phenotype; diagnostic** | **Highest — gold standard** | | **Bone marrow biopsy** | Shows lymphoid infiltration; supportive but not diagnostic | Moderate — morphology alone is non-specific | | **Serum protein electrophoresis** | Detects monoclonal spike if present; not diagnostic | Low — absent in ~30% of CLL cases | | **Lymph node biopsy** | Histology shows small lymphocyte infiltration; invasive and unnecessary | Moderate — reserved for atypical presentations | **Clinical Pearl:** Flow cytometry is rapid (24–48 hours), non-invasive, and requires only peripheral blood — no biopsy needed. It also allows simultaneous assessment of: - Absolute lymphocyte count - Clonality (monoclonal vs. polyclonal) - Prognostic markers (CD38, ZAP-70 expression; TP53 mutations by other methods) ## Diagnostic Algorithm for Suspected CLL ```mermaid flowchart TD A[Absolute lymphocytosis on CBC]:::outcome A --> B[Peripheral blood smear]:::action B --> C{Small mature lymphocytes?}:::decision C -->|Yes| D[Perform flow cytometry]:::action D --> E{CD5+ CD19+ CD23+?}:::decision E -->|Yes| F[CLL confirmed]:::outcome E -->|No| G[Consider other lymphoproliferative disorder]:::action G --> H[Mantle cell: CD5+ CD23-]:::outcome G --> I[Marginal zone: CD5- CD23+]:::outcome C -->|No| J[Reconsider diagnosis]:::action ``` **Mnemonic:** **CD5-CD19-CD23 = CLL** (the "triple positive" B-cell phenotype) **Warning:** Do not confuse CLL with mantle cell lymphoma (CD5^+^ CD23^−^) or marginal zone lymphoma (CD5^−^ CD23^+^). Flow cytometry distinguishes these by the complete immunophenotype.